FT Options LLC - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
FT Options LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$64,000
-41.3%
17,7360.0%0.07%
-15.1%
Q3 2016$109,000
+94.6%
17,736
+17.8%
0.09%
+79.2%
Q2 2016$56,00015,0590.05%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,857,667$10,573,00010.68%
Clarus Ventures, LLC 2,752,488$10,184,0008.91%
Rhenman & Partners Asset Management AB 345,100$1,277,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 203,243$752,0000.20%
Camber Capital Management LP 1,000,000$3,700,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 643,580$2,381,0000.09%
FT Options LLC 15,059$56,0000.05%
FRED ALGER MANAGEMENT, LLC 86,782$321,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 27,700$102,0000.00%
FIRST NEW YORK SECURITIES LLC /NY 750$2,775,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders